Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

May 30, 2025

Study Completion Date

July 31, 2025

Conditions
ADHDParenting
Interventions
BEHAVIORAL

Behavioral Parent Training

Parents will receive 10 sessions of behavioral parent training with components specifically targeted toward parents with ADHD. Treatment will be delivered via telehealth.

DRUG

Extended release mixed amphetamine salts (MAS)

The MAS protocol will include a 2-4 -week open-label titration beginning at 20 mg and dose level will be increased weekly at telehealth visits with the psychopharmacologist until an optimal response or maximum dose of 60 mg.

Trial Locations (1)

20742

University of Maryland, College Park

All Listed Sponsors
collaborator

Children's National Research Institute

OTHER

collaborator

University of Michigan

OTHER

collaborator

Seattle Children's Hospital

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Maryland, College Park

OTHER